22. T.E. Beckert, K. Lehmann, and P.C. Schmidt, Int. J. Pharm.
143 (1), 13–23 (1996).
23. G. Ragnarsson et al., Drug Dev. Ind. Pharm.
13 (9–11), 1495–1509 (1987).
24. G.P. Millili and J.B. Schwartz, Drug Dev. Ind. Pharm.
16 (8), 1411–1426 (1990).
25. B. Johansson et al., Int. J. Pharm.
117 (1), 57–73 (1995).
26. F. Nicklasson and G. Alderborn, Pharm. Res.
17 (8), 947–952 (2000).
27. Y.S. Habib, L.L. Augsburger, and R.F. Shangraw, Int. J. Pharm.
233 (1–2), 67–83 (2002).
28. S.R. Bechard and J.C. Leroux, Drug Dev. Ind. Pharm.
18 (18), 1927–1944 (1992).
29. V.S.N.M. Dwibhasyam, Ind. J. Pharm. Sci.
70 (5), 555–564 (2008).
30. A. Tuton, J. Grasjo, and G. Alderborn, Eur. J. Pharm. Sci.
19 (5), 333–344 (2003).
31. M. Celik and L. Maganti, Drug Dev. Ind. Pharm.
20 (20), 3151–3173 (1994).
32. S.R. Bechard and J.C. Leroux, Drug Dev. Ind. Pharm.
18 (18), 1927–1944 (1992).
33. J.J. Torrado and L.L. Augsburger, Int. J. Pharm.
106 (2), 149–155 (1994).
34. H. Haubitz, W. Mehnert, and K.H. Fromming, Pharm. Ind.
58 (1), 83–86 (1996).
35. L. Stubberud et al., Pharm. Dev. Technol. 3 (2), 141–151 (1998).
36. H. Yuasa et al., S.T.P. Pharma Sci.
11 (3), 221–228 (2001).
37. T. Yao et al., Chem. Pharm. Bull.
46 (5), 826–830 (1998).
38. G.J. Vergote et al., Eur. J. Pharm. Sci.
17 (3), 145–151 (2002).
39. J. Hogan, "Coating of tablets and multiparticulates," in Pharmaceutics: The Science of Dosage Form Design, M.E. Aulton, Ed. (Churchill Livingstone, Edinburgh, 2002), pp.441–448.
40. R.K. Chang and E.M. Rudnic, Int. J. Pharm.
70 (3), 261–270 (1991).
41. K. Lehmann, H.U. Petereit, and D. Dreher, Pharm. Ind.
55 (10), 940–947 (1993).
42. A. Onions, Manuf. Chem.
57 (3), 55–59 (1986).
43. A. Onions, Manuf. Chem.
57 (4), 66–67 (1986).
44. J.T. Heinamaki et al., Pharm. Ind.
57 (1), 68–71 (1995).
45. M.E. Aulton, Int. J. Pharm. Technol. Prod. Manuf.
3 (1), 9–16 (1982).
46. L.A. Felton et al., S.T.P. Pharma Sci.
7 (6), 457–462 (1997).
|
